Editorial Board
The Journal of Medical Genetics Editor and Associate Editors have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.
Editor-in-Chief

Dr Huw Dorkins
University of Oxford
Oxford, UK
orcid.org/0000-0001-8421-9939
Huw Dorkins, FRCP FRCPath, is a clinical geneticist. His academic base is at the University of Oxford, where he Fellow & Tutor in Medicine at St Peter’s College. His clinical work is with the Leicestershire Genetics Service, Leicester, UK. His interests are in the areas of cancer genetics, neurogenetics and genetics education.
Declaration of Interests, see here

Associate Editors


Dr Hui-Qi Qu
Children’s Hospital of Philadelphia
Philadelphia, USA
orcid.org/0000-0001-9317-4488
Hui-Qi Qu, MB, PhD, is a Principal Scientist at the Center for Applied Genomics at the Children’s Hospital of Philadelphia, US. With a physician background in internal medicine, his research focuses on genetics and precision medicine. His contributions include identifying Type 1 Diabetes loci and driving genomic research in complex diseases.



Professor Enza-Maria Valente
University of Pavia
Rome, Italy
orcid.org/0000-0002-0600-6820
Dr Valente is Full Professor of Medical Genetics at University of Pavia and Head of Neurogenetics Research Center at the IRCCS Mondino Foundation, in Pavia, Italy. Her main research interest is Parkinson Disease (PD) genetics. Over the years, she contributed knowledge on the mutational spectrum, phenotypes and molecular functions of several PD-genes, with focus on PINK1, GBA and SNCA. She coordinates the Italian National Virtual Institute of Parkinson Disease, and is a member of the Scientific Committee and Monogenic Network of ASAP Global Parkinson’s Genetic Program (GP2).

Social Media Editor

Rita Barbosa-Matos, BSc, MSc
i3s - Institute for Research and Innovation in Health
Porto, Portugal
orcid.org/0000-0003- 0794-4912
Rita Barbosa-Matos, who holds a PhD in Molecular and Cellular Biotechnology Applied to Health Sciences, specializes in rare tumour risk syndromes with a focus on translational applications for cancer prevention and clinical care. Her research emphasizes studying genetic modifiers of disease lifetime risks and developing patient-derived models using induced pluripotent stem cells (iPSCs) and organoids. Currently, she works with families affected by Hereditary Diffuse Gastric Cancer (HDGC). She is also an active contributor to the scientific community, serving as a member of the Education and Young Representatives Committees of the European Society of Human Genetics, and the Communication Committee of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

Publishing Team
Publishing Executive: Anna Savage
Senior Publisher: Henry Spilberg
Head of Portfolio: Kathleen Lyons